Literature DB >> 12239182

V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo.

Delin Zhu1, Jennifer Orchard, David G Oscier, Dennis H Wright, Freda K Stevenson.   

Abstract

Tumors of the splenic marginal zone can present in spleen or blood. The maturational status of the neoplastic B cells from each site appears heterogeneous, with either unmutated or mutated variable-region heavy chain (V(H)) genes. To determine an influence of tissue location, we assessed matched blood and splenic tumor cells from 4 patients and found them identical. However, one patient with unmutated V(H) genes in blood and spleen developed a clonally related diffuse large B-cell lymphoma in the chest wall. Strikingly, this subclone had undergone significant somatic mutation, with clear intraclonal heterogeneity. To our knowledge, this is the first case of a B-cell tumor showing initiation of somatic mutation in vivo. The finding emphasizes that the tissue microenvironment can influence tumor cell behavior and possibly affect disease progression. Importantly, because several replacement mutations were located within or close to the complementarity-determining regions (CDRs), it raises the question of a role for antigen in driving tumor growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239182     DOI: 10.1182/blood-2002-01-0169

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.

Authors:  Silvia Zibellini; Daniela Capello; Francesco Forconi; Paolo Marcatili; Davide Rossi; Sara Rattotti; Silvia Franceschetti; Elisa Sozzi; Emanuele Cencini; Roberto Marasca; Luca Baldini; Alessandra Tucci; Francesco Bertoni; Francesco Passamonti; Ester Orlandi; Marzia Varettoni; Michele Merli; Silvia Rizzi; Valter Gattei; Anna Tramontano; Marco Paulli; Gianluca Gaidano; Luca Arcaini
Journal:  Haematologica       Date:  2010-05-29       Impact factor: 9.941

2.  Tumorigenic potential and disease manifestations of malignant B-cell variants differing in their fibronectin adhesiveness.

Authors:  Liat Nadav; Vyacheslav Kalchenko; Meir Max Barak; Elizabeth Naparstek; Benjamin Geiger; Ben-Zion Katz
Journal:  Exp Hematol       Date:  2008-08-09       Impact factor: 3.084

3.  Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.

Authors:  Kostas Stamatopoulos; Chrysoula Belessi; Theodora Papadaki; Evangelia Kalagiakou; Niki Stavroyianni; Vassiliki Douka; Stavroula Afendaki; Riad Saloum; Aikaterini Parasi; Dimitra Anagnostou; Nikolaos Laoutaris; Athanasios Fassas; Achilles Anagnostopoulos
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

Review 4.  Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes.

Authors:  Xavier Troussard; Edouard Cornet
Journal:  Curr Treat Options Oncol       Date:  2007-04

5.  Immunoglobulin gene repertoire diversification and selection in the stomach - from gastritis to gastric lymphomas.

Authors:  Miri Michaeli; Hilla Tabibian-Keissar; Ginette Schiby; Gitit Shahaf; Yishai Pickman; Lena Hazanov; Kinneret Rosenblatt; Deborah K Dunn-Walters; Iris Barshack; Ramit Mehr
Journal:  Front Immunol       Date:  2014-06-03       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.